• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/25

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

25 Cards in this Set

  • Front
  • Back
Definition of Glaucoma
• A spectrum of ophthalmic disorders
characterized by neuropathy of the optic
nerve and loss of retinal ganglion cells
which leads to permanent deterioration
of the visual field and potentially total
vision loss.
Subjective data for open-angle(3)
-symptoms presented
-effect on vision
-often asymptomatic
-loss of peripheral vision
-Blind spots in field of vision
Subjective data for angle-closure
• Ocular pain
•Red eye
• Blurred vision
• Halos around lights
• Other: nausea,
vomiting, abdominal
pain, headache,
diaphoresis

*Vision loss can occur as soon as hours to days
Glaucoma objective data
• Routine eye exam
• Optic nerve head cupping
• Large cup-disc ratio
• Diffuse thinning
• IOP > 21 mmHg (not required)
• Pachymetry: corneal thickness (< 540 microns)
•Perimetry
• Gonioscopy
Which glaucoma has higher pressure?
Angle closure(40-50mmHg)
ACG non-pharmacologic tx
Surgical iridotomy
laser iridotomy(as opposed to trabecular)
First line OAG tx

how to monitor

Alt. first line?
Beta blocker(assess response 2-4 weeks)

alt: Prostaglandin or brimonidine
Patient-related variables for BB(Betaxolol)?
COPD, bradycardia, CHF
agent-related variables for BB?(Betaxolol, Timolol)
– First line
– Betaxolol (selective antagonist - ?safer pulm)
– Tachphylaxis 20-50%
– ?long-term tolerance
– BAK preservative
BB indices of toxicity(Betaxolol, Timolol)
– ADEs:
• Local: stinging, conjunctivitis, keratitis, dry eyes,
uveitis
• Systemic: pulmonary, cardiovascular
– Timolol: tachyphylaxis (20-50%)
Agent-related variables with Prostaglandin analogs
– First line option
– Alternative to beta-blocker (intolerant or
contraindicated patients)
– Becoming gold standard: excellent safety
– Preservative-free
–QHS
Prostaglandin analog indices of toxicity
– Local: conjunctival hyperemia, stinging, iris
pigmentation, hypertrichosis, darkening of
eyelashes
– Systemic: rare
Agent-related variables of alpha-2-agonist(Apraclonidine, brimonidine)
– ? Neuroprotective (Low-Pressure Glaucoma
Treatment Study)
– Prevention and treatment post-surgical IOP
elevations
– Not used long-term: brimonidine better LT than
apraclonidine
Indices of toxicity in Alpha-2-agonist(Apraclonidine, brimonidine)
– Local: blepharoconjunctivitis, foreign body
sensation, pupillary mydriasis, eyelid
retraction
– Systemic: headache, dry mouth, fatigue
Pt related variables for cholinergic agonist
– Dark irides
– Severe myopia
Agent-related variables for cholinergic agonist(carbachol, pilocarpine)
– First line option
– Pilocarpine gel Qday admin
– QID admin
– ?long-term: cataracts
Indices of toxicity for cholinergic agonist(carbachol, pilocarpine)
– Local: accomodation spasm, myopia, brow
ache, decreased night vision
– Systemic: nausea, vomiting diarrhea,
bradycardia
When other drugs fail use these...
Che inhibitors(echothiphate)
Avoid these if allergic to sufa
Carbonic anhydrase inhibitor(brinzolamide, acetazolamide)
Agent-related variables of carbonic anhydrase inhibitors(Brinzolamide, acetazolamde, dichlophenamide)
– Adjunctive or monotherapy alternative
– Systemic: use in acute ACG otherwise 3rd line
d/t ADEs
Carbonic anhydrase inhibitor indices of toxicity(Brinzolamide, Dorzolamide, acetazolamide, dichlophenamide, methazolamide)
– Local: burning, stinging, itching, foreign body
sensation, dry eyes, conjunctivitis, irreversible corneal
decompensation, taste abnormalities
– Systemic: paresthesias, nausea, vomiting, weight
loss, acidosis, hypo K+, hypo Na+, nephrolithiasis
Benefits of Combo tx(potential)
• Improved efficacy
• Reduce exposure to preservatives
• Simplified regimens
•Cost ?
• Increased adherence
RFs for OAG
Elevated IOP
African or hispanic
FH
Older
Thinner Central corneal thickless
RFs for ACG
Advancing age
Asian or Eskimo
Female
Hyperopia
Shallow anterior chamber
FH